US 11661459
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
granted A61KA61K2039/507A61K2239/31
Quick answer
US patent 11661459 (Artificial cell death polypeptide for chimeric antigen receptor and uses thereof) held by Century Therapeutics, Inc. expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Century Therapeutics, Inc.
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/507, A61K2239/31, A61K2239/38, A61K2239/48